A Firm Incubated by ZGC Life Science Park was Approved for IPO on SSE STAR Market


On the morning of November 10, the Stock Listing Committee of SSE STAR Market had its 101st reviewing meeting of 2020. At the meetingBeijing NovoGene Technology co., Ltd., a company incubated by ZGC Life Science Park under ZGC Development Group, was approved for IPO on SSE STAR Market, with CITICS as its sponsor institution.

Incorporated at ZGC Life Science Park in the March of 2011, NovoGene is a genomics solution provider, focusing on the application of the molecular biological technology and high-performance computing technology in the field of life science and human health. It is committed to be the world’s leading provider of genetic technology offerings. 

Looking forward, ZGC Life Science Park will continuously improve the ecosystem of business incubation, boost the level of incubation services, supporting and accompanying the firms in their innovation-driven development and healthy growth. 


Previous page:ZGC Science and Technology Service Company and Aliyun Jointly Create a Digital Technological Innovation Service Platform Next page:Maxwell Innovation Science Experimental Park of Beijing Institute of Nanometer Energy Opens to the Public